https://trademarketresearch.com/143...growing-number-of-applications-in-the-market/
Duchenne Muscular Dystrophy Therapeutics Market is expected to witness high demand on account of the growing number of applications in the market
Market Segment by Manufacturers, this report covers:
Bristol-Myers Squibb (market cap 94 billion)
FibroGen (U.S.) (market cap 4.5 billion)
Italfarmaco (Italy)
Marathon
NS Pharma (U.S.)
PTC Therapeutics (U.S.) (market cap 1.9 billion)
Pfizer (market cap 260 billion)
ReveraGen BioPharma (U.S.)
Santhera Pharmaceuticals (Switzerland)
Sarepta Therapeutics (U.S.) (market cap 9.1 billion)
What's the market cap of little old ANP?!
- Forums
- ASX - Day Trading
- morning traders 17 / 10
morning traders 17 / 10, page-73
-
- There are more pages in this discussion • 201 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order